Risk-stratified management to remove low-risk penicillin allergy labels in the patients with COVID-19 in the intensive care unit

Affiliations

• ¹ Department of Pharmaceutical Services, Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tenn.
• ² Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn.
• ³ Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tenn.
• ⁴ Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, Tenn.
• ⁵ Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tenn.
• ⁶ Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tenn; Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tenn; Institute for Immunology & Infectious Diseases, Murdoch University, Murdoch, WA, Australia.
• ⁷ Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn. Electronic address: cosby.a.stone@vumc.org.